Validating controlled attenuation parameter in the assessment of hepatic steatosis in living liver donors.
<h4>Introduction</h4>Hepatic steatosis (HS) negatively impacts transplant outcomes in living liver donors. To date, liver biopsy is preferred for HS evaluation. This study aims to evaluate the measurement of controlled attenuation parameter (CAP) as a diagnostic tool of HS in living live...
Saved in:
Main Authors: | Dieter Broering, Mohamed Shawkat, Ali Albenmousa, Faisal Abaalkhail, Saleh Alabbad, Waleed Al-Hamoudi, Saad Alghamdi, Saleh Alqahthani, Ahmad Jaafari, Roberto Troisi, Khalid Bzeizi |
---|---|
Format: | article |
Language: | EN |
Published: |
Public Library of Science (PLoS)
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/562cc6dc058f45cbb183915d3b4a4d78 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The comparison of pancreatic and hepatic steatosis in healthy liver donor candidates
by: Bedriye Koyuncu Sokmen, et al.
Published: (2021) -
Effect of COVID-19 on liver abnormalities: a systematic review and meta‐analysis
by: Khalid Bzeizi, et al.
Published: (2021) -
Role of PAI-1 in hepatic steatosis and dyslipidemia
by: Joshua A. Levine, et al.
Published: (2021) -
Cellular senescence drives age-dependent hepatic steatosis
by: Mikolaj Ogrodnik, et al.
Published: (2017) -
Hepatic Steatosis Index Is Associated with Type 1 Diabetes Complications
by: Tripolino C, et al.
Published: (2019)